Are the Abrika's double-scored and blue...the 20s? My friend gets those. I've never seen them anywhere, but the bottle said amphetamine salts. I think Abrika was the manufacturer.
Anyways, Shire owns the patent on Adderall. It got it approved in 1996. Glaxo-Smith Kline (AKA: Smith, Kline and French, AKA: Smith-Kline Beecham, which is why the tablets have SKF and the caps SB ) make Dexedrine. BARR is the largest manufacturer of Adderall and Dexedrine generics, while there are other generic pharmaceutical companies out there. Adderall XR is still under patent, so Shire is the only one who makes them. There is no point in buying BARR Dexedrine, since the GSK is like $.50 for a tablet and the 15mg capsules are like $1.50. The Generic is like $.40, and $1.30, respectively. An Adderall XR 15mg. is $3.00. That's on reason for not taking the generics, but I pay the same for both through insurance.
It's not like arguing over girth and length, since they can be measured, this is a subjective question.
Here's some info about what I mentioned earlier:
"-1952:
As early as 1945, researchers at Smith Kline & French began evaluating the therapeutic advantages of coatings for tablets.
Chemists also started searching for chemical or mechanical techniques that would gradually release drugs for a predictable therapeutic effect over an entire day or night.
By 1949, Donald McDonnell realised the possible solution to the release-action puzzle, which was to fill capsules with pellets coated with medication that would dissolve at different times.
Because of the complexities of implementation and adaptation to large-scale manufacturing, it was not until 1952 that the time-released capsule known as a Spansule was used and marketed.
It was first used for Dexedrine (dextroamphetamine sulfate) for treating psychiatric patients of certain types and patients suffering from depression, fatigue or listlessness, and for patients afflicted with narcolepsy.
The Spansule provided a novel form of drug delivery, which was a major therapeutic breakthrough. It quickly released the required initial dose and then slowly and gradually released many extremely small doses to maintain a therapeutic level lasting from 10 to 12 hours, providing all-day or all-night therapy with one dose.
Subsequently, the firm marketed a number of other sustained-release preparations, one of which is the cold remedy Contac. Launched in 1960, Contac later became the world's leading cold remedy.
More than seven years of research and more than 35,000 hours of work were required to develop the sustained-release capsule, Spansule."
